Table 3 Insulin resistance indices according to lipodystrophy defined clinically and by FMR
Lipodystrophy defined clinically | defined by FMR | ||||||
|---|---|---|---|---|---|---|---|
Total | Without CL | With CL | P | Without L | With L | P | |
HOMA-IR [median (IQR)] | 1.9 (2.8) | 1.7 (2.4) | 2.1 (3.0) | 0.229 | 1.6 (2.6) | 2.8 (2.8) | <0.001 |
HOMA-B [median (IQR)] | 92.3 (106.4) | 92.3 (91.1) | 91.8 (117.5) | 0.855 | 92.3 (96.1) | 85.4 (120.8) | 0.633 |
QUICKI [median (IQR)] | 0.34 (0.06) | 0.35 (0.06) | 0.34 (0.06) | 0.229 | 0.36 (0.07) | 0.33 (0.05) | <0.001 |
MATSUDA [median (IQR)] | 4.8 (5.1) | 5.0 (4.2) | 4.7 (5.4) | 0.735 | 5.9 (5.3) | 4.1 (4.4) | 0.002 |
Glucose [mg/dL, median (IQR)] | 93.5 (26.0) | 90.0 (23.0) | 97.0 (35.5) | 0.046 | 90.0 (23.0) | 97.0 (35.5) | 0.002 |
Insulin [μU/mL, median (IQR)] | 8.1 (9.6) | 7.9 (8.2) | 9.0 (10.2) | 0.365 | 7.5 (8.1) | 10.1 (9.9) | 0.003 |
A1c [% median (IQR)] | 5.3 (0.7) | 5.2 (0.6) | 5.3 (0.9) | 0.091 | 5.2 (0.6) | 5.5 (0.9) | 0.002 |